REGULUS THERAPEUTICS INC.

(RGLS)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
1.720 USD   +4.24%
08/11REGULUS : Q2 Earnings Snapshot
AQ
08/11TRANSCRIPT : Regulus Therapeutics Inc., Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11REGULUS THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart REGULUS THERAPEUTICS INC.
Upcoming events on REGULUS THERAPEUTICS INC.
11/10/22 Q3 2022 Earnings Release (Projected)
03/08/23 FY 2022 Earnings Release (Projected)
05/11/23 Q1 2023 Earnings Release (Projected)
08/10/23 Interim 2023 Earnings Release (Projected)
Past events on REGULUS THERAPEUTICS INC.
08/11/22 | 05:00pm Interim 2022 Earnings Call
08/11/22 Interim 2022 Earnings Release
06/29/22 REVERSE SPLIT: 1 of 10
06/09/22 | 12:00pm Annual General Meeting
05/24/22 | 07:00am H.C. Wainwright Global Life Sciences Investment Conference
05/12/22 | 05:00pm Q1 2022 Earnings Call
05/12/22 | 04:05pm Q1 2022 Earnings Release
04/12/22 Wells Fargo Biotech Forum
03/10/22 | 05:00pm FY 2021 Earnings Call
03/10/22 | 04:05pm FY 2021 Earnings Release
Past dividends on REGULUS THERAPEUTICS INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
0,07
0,11
-32%
0,07
3,57
-98%
6,83
6,86
-0,38%
10,0
5,02
99%


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-70,1
-70,8
0,88%
-46,8
-43,0
-8,7%
-16,8
-17,2
2,2%
-14,2
-19,2
26%
-27,8
-27,4
-1,4%
 
-27,3
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-72,1
-72,3
0,25%
-48,6
-44,8
-8,6%
-18,6
-18,9
1,9%
-15,7
-20,9
25%
-27,8
-26,9
-3,4%
 
-27,7
 
Net income
M $
Released
Forecast
Spread
-71,9
-72,2
0,37%
-48,7
-44,8
-8,7%
-18,6
-18,9
1,9%
-15,7
-20,9
25%
-27,8
-26,9
-3,4%
 
-27,7
 
EPS
$
Released
Forecast
Spread
-115
-120
4,2%
-55,9
-33,3
-68%
-10,8
-11,0
1,8%
-4,50
-6,60
32%
-3,20
-3,27
2,0%
 
-1,47
 
Announcement Date03/07/201803/18/201903/12/202003/09/202103/10/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread

0,01
 

0,00
 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-6,64
-5,88
-13%
-8,42
-6,50
-30%
-6,96
-6,57
-5,9%
-6,57
-7,21
8,8%
-7,18
-7,05
-1,8%
 
-6,80
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-6,03
-6,03
-0,12%
-8,63
-6,31
-37%
-7,13
-6,14
-16%
-6,72
-7,20
6,7%
-7,26
-7,14
-1,7%
 
-6,80
 
Net income
M $
Released
Forecast
Spread
-6,03
-6,03
-0,14%
-8,63
-6,31
-37%
-7,13
-6,14
-16%
-6,72
-7,20
6,7%
-7,26
-7,14
-1,7%
 
-6,84
 
EPS
$
Released
Forecast
Spread
-0,80
-0,80
0,00%
-1,00
-0,78
-29%
-0,70
-0,67
-5,0%
-0,50
-0,53
6,2%
-0,50
-0,49
-3,1%
 
-0,46
 
Announcement Date08/10/202111/10/202103/10/202205/12/202208/11/2022-
Previous year Next Year
Upcoming sector events for REGULUS THERAPEUTICS INC.
More events
Past sector events for REGULUS THERAPEUTICS INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise